Profile: Bruno Sepodes, Europe's Orphan Chief (AKA Batman), Who Loves Companies To Get Help
This article was originally published in Scrip
Bruno Sepodes is the chair of the European Medicines Agency's Committee for Orphan Medicinal Products, the body that effectively decides whether your product wins and keeps its orphan status. In Scrip's latest industry profile, he talked about helping companies chase their dreams, where they go wrong and how for 10 years he led a double life as a Body Balance instructor.
You may also be interested in...
While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.